Resource Center
Always with a focus on innovation, find resources that share our scientific experts passion and knowledge. Find case studies, info sheets, posters and more.
De-Risking FIH: Integrated Strategies for Rapid Proof-of-Concept
Download61 - 66 of 232 results
Safety, tolerability, and pharmacokinetics of the oligomer modulator anle138b: a first-in-human randomized, double-blind, placebo-controlled Phase 1 trial
14 December 2022ISSX 2022: A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes
14 December 2022Practical and operational considerations related to pediatric oral drug formulation: An industry survey
14 December 2022Understanding the Absorption, Metabolism and Excretion of Masitinib in Healthy Male Subjects
14 December 2022ESMO Immuno-Oncology Poster: Hubro Therapeutics QSC204718 (Vaccine Study)
13 December 2022ACoP 2022 Poster: Benznidazole pharmacokinetics in adults and children: Application of PBPK modelling
13 December 2022Learn about Quotient Sciences' services
Where integrated CRDMO services bring therapies to life. Whether it's meeting your first-in-human milestone, confidently advancing your program to proof-of-concept, or providing a trusted supply of clinical trial materials or commercial drug product, learn about Quotient Sciences CRDMO offering and how we can support your next drug program.